about
RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin lociHLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.Host thiopurine methyltransferase status affects mercaptopurine antileukemic effectiveness in a murine modelA comprehensive evaluation of collapsing methods using simulated and real data: excellent annotation of functionality and large sample sizes required.The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.Effect of premedications in a murine model of asparaginase hypersensitivityEbf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.Functional characterization of liver enhancers that regulate drug-associated transporters.Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate dispositionNALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cellsAntileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse ModelPACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicityGenetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia.Genome-wide study of methotrexate clearance replicates SLCO1B1.Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors.Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.B cell receptor basal signaling regulates antigen-induced Ig light chain rearrangements.Impact of Pharmacogenetics on Efficacy and Safety of Statin Therapy for Dyslipidemia.Tonic BCR signaling represses receptor editing via Raf- and calcium-dependent signaling pathways.IL-7 functionally segregates the pro-B cell stage by regulating transcription of recombination mediators across cell cycle.Sleeping Beauty Screen Identifies RREB1 and Other Genetic Drivers in Human B-cell LymphomaAsparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemiaDelayed methotrexate clearance in patients with acute lymphoblastic leukemia concurrently receiving dasatinibInterpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service ProvidersPharmacogenetics of treating pediatric anxiety and depression
P50
Q28508203-AADF1CC7-9883-417C-A15F-9090B9D36B68Q30371340-525D6353-C14A-4B1D-A4B8-E5B542A23A1FQ33603164-8CFC5256-484C-4891-9233-323738465C3CQ34180858-84D10F17-5BEE-48D4-A7AD-009DCFA0C55EQ34216710-55112065-A118-4CD9-8FD0-E2009BF848F2Q34267235-0876B232-7521-483C-B4ED-7B860C81ABA9Q34276618-930215E4-155C-4D33-A220-61984FD0DC6EQ35156439-3A51D454-A9C7-45F4-AAFB-6E0036AD663CQ35213566-16A116E4-11D4-48A7-84F7-9AF836EA690CQ35583006-78340945-B7D3-471A-A924-ADB7343DE009Q35634476-7DC5B90A-6106-448A-A3D5-AC93628B82D9Q35665990-FF76B751-EBFE-43E7-8867-FA7EEB334172Q35740019-B376C747-4E5E-40C5-B22B-55010F3CACBEQ35820373-502A09F2-7BC0-454B-83E6-5AF1A61174C2Q35954058-CEB25663-5B8F-4E40-9128-7EC2A685EA3BQ36317718-85B49ECB-3D6E-4972-9F43-0DFC0A70230EQ36547791-7C3D9E2F-6CB0-4C28-850F-D3A12B6B7730Q36595293-3549E3B8-1CF9-498E-A0BA-6200BEBE23E2Q37503137-D940B78C-255E-40FD-9FD3-1372D496B575Q38169633-067E730F-154D-4927-9411-415BE84B51CDQ38292514-81408D0F-CB49-40F4-9426-C6DAB1B46558Q38663481-52A080EE-DA3D-4140-9F28-A31AC2E5D35EQ41969243-38F795E2-0612-4985-A1B2-61DC54BBB4B7Q42187226-DF64E9E5-5F68-4401-88D6-001B1C3E4E0AQ57793314-69C13917-2614-4188-837E-942DF440879BQ90709819-6FF4D952-E6C8-4938-B423-41A758A042F6Q91197807-210E2353-11B6-41BE-AB7C-1DDC66487EBAQ92513314-9709AB03-0BEC-46A2-99DF-E5BBEEAD4EEAQ92896593-36A5A42E-9EAA-4AA7-9134-09723DCCF1B3
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Laura B Ramsey
@ast
Laura B Ramsey
@en
Laura B Ramsey
@es
Laura B Ramsey
@nl
Laura B Ramsey
@sl
type
label
Laura B Ramsey
@ast
Laura B Ramsey
@en
Laura B Ramsey
@es
Laura B Ramsey
@nl
Laura B Ramsey
@sl
altLabel
Ramsey LB
@en
prefLabel
Laura B Ramsey
@ast
Laura B Ramsey
@en
Laura B Ramsey
@es
Laura B Ramsey
@nl
Laura B Ramsey
@sl
P106
P21
P2798
P31
P496
0000-0001-6417-3961